Exelixis (EXEL) Sales of Property, Plant and Equipment (2010 - 2017)

Exelixis (EXEL) Sales of Property, Plant and Equipment (2010 - 2017) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 27,000.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Exelixis 14.44 Bn 13.66 Bn 590.86 Mn -

Historic Data

Download Data
DateValue
Dec 29, 2017 150,000.00
Dec 29, 2017 150,000.00
Jun 30, 2017 10,000.00
Jun 30, 2017 10,000.00
Mar 31, 2017 4,000.00
Mar 31, 2017 4,000.00
Dec 30, 2016 -1.20 Mn
Dec 30, 2016 -1.20 Mn
Sep 30, 2016 -20,000.00
Sep 30, 2016 -20,000.00
Jun 30, 2016 5,000.00
Jun 30, 2016 5,000.00
Mar 31, 2016 107,000.00
Mar 31, 2016 107,000.00
Sep 30, 2015 5,000.00
Sep 30, 2015 5,000.00
Jun 30, 2015 656,000.00
Jun 30, 2015 656,000.00
Mar 31, 2015 639,000.00
Mar 31, 2015 639,000.00